Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.055 USD | +7.68% | +16.08% | +0.91% |
05-13 | Wall Street Set to Open Higher Monday as Investors Look Toward Key Inflation Figures | MT |
05-13 | MiNK Therapeutics, Inc. announced that it expects to receive $5.8 million in funding | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 34M 46.43M |
---|---|---|---|---|---|
Net income 2024 * | -19M -25.94M | Net income 2025 * | -36M -49.16M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.9
x | P/E ratio 2025 * |
-1.48
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.67% |
Latest transcript on MiNK Therapeutics, Inc.
1 day | +7.68% | ||
1 week | +16.08% | ||
Current month | +9.06% | ||
1 month | +18.84% | ||
3 months | +8.01% | ||
6 months | +13.65% | ||
Current year | +0.91% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Buell
CEO | Chief Executive Officer | 50 | 21-01-31 |
Heather Boussios
CMP | Compliance Officer | - | - |
Marc van Dijk
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CHM | Chairman | 71 | 17-06-30 |
Director/Board Member | 66 | 17-06-30 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 21-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 1.065 | +8.70% | 339 772 |
24-05-13 | 0.9798 | +8.87% | 4,583,316 |
24-05-10 | 0.9 | +0.08% | 20,100 |
24-05-09 | 0.8993 | -3.30% | 135,759 |
24-05-08 | 0.93 | -0.01% | 18,987 |
Delayed Quote Nasdaq, May 14, 2024 at 12:31 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.91% | 34M | |
+29.62% | 48.16B | |
-0.99% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.16% | 25.59B | |
-22.96% | 18.96B | |
+8.48% | 12.92B | |
+29.05% | 12.03B | |
-1.96% | 11.77B |
- Stock Market
- Equities
- INKT Stock